Hematologic and oncologic emergencies

References

• Krecker E, Muggia F. Oncologic emergencies. In: Brain MP, Carbone PP, eds. Current therapy in hematology-oncology. St Louis: Mosby, 1995: 600–1
   Google Scholar
• Fox K. Oncologic emergencies. In: Macdonald J, Haller D, Mayer R, eds. Manual of oncologic therapeutics. Philadelphia: Lippincott, 1995: 347–77
   Google Scholar
• Problems common to cancer and its therapy. In: Abeloff MD, Armitage JO, Lichter AS, et al, eds. Clinical oncology. New York: Churchill Livingstone, 1995: 355–599
   Google Scholar
• Schilsky RL. Renal and metabolic toxicities of cancer chemotherapy. Semin Oncol 1982; 9(1): 75–83
   Google Scholar
• Conger JD, Falk SA. Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy. J Clin Invest 1977; 59(5): 786–93
   PubMed Web of Science ®Google Scholar
• Mundy GR. Malignancy and the skeleton. Horm Metab Res 1997; 29(3): 120–7
   Google Scholar
• Chisholm MA, Mulloy AL, Taylor AT. Acute management of cancer-related hypercalcemia. Ann Pharmacother 1996; 30(5): 507–13
   Google Scholar
• Sorensen JB, Andersen MK, Hansen HH. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. J Intern Med 1995; 238(2): 97–110
   Web of Science ®Google Scholar
• Sterns RH, Riggs JE, Schochet SS Jr. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med 1986; 314(24): 1535–42
   Google Scholar
• Kamel KS, Quaggin S, Scheich A, et al. Disorders of potassium homeostasis: an approach based on pathophysiology. Am J Kidney Dis 1994; 24(4): 597–613
   Google Scholar
• Mandai AK. Hypokalemia and hyperkalemia. Med Clin North Am 1997; 81(3): 611–39
   Google Scholar
• Abner A. Approach to the patient who presents with superior vena cava obstruction. Chest 1993; 103(4 Suppl): 394–7S
   Google Scholar
• Yellin A, Rosen A, Reichert N, et al. Superior vena cava syndrome: the myth—the facts. Am Rev Respir Dis 1990; 141 (5 Pt 1): 1114–8
   Google Scholar
• Painter TD, Karpf M. Superior vena cava syndrome: diagnostic procedures. Am J Med Sci 1983; 285(3): 2–6
   Google Scholar
• Jahangiri M, Taggart DP, Goldstraw P. Role of mediastinoscopy in superior vena cava obstruction. Cancer 1993; 71 (10): 3006–8
   Google Scholar
• Grant R, Papadopoulos SM, Greenberg HS. Metastatic epidural cord compression. Neurol Clin 1991; 9(4): 825–40
   Google Scholar
• Boogerd W, van der Sander JJ. Diagnosis and treatment of spinal cord compression in malignant disease. Cancer Treat Rev 1993; 19(2): 129–50
   Google Scholar
• Jordan JE, Donaldson SS, Enzmann DR. Cost effectiveness and outcome assessment of magnetic resonance imaging in diagnosing cord compression. Cancer 1995; 75(10): 2579–86
   Google Scholar
• Abramson AF, Mitty HA. Update on interventional treatment of urinary obstruction. Urol Radiol 1992; 14(3): 234–6
   Google Scholar
• Ortlip SA, Fraley EE. Indications for palliative urinary diversion in patients with cancer. Urol Clin North Am 1982; 9(1): 79
   Google Scholar
• Shepherd FA, Ginsberg JS, Evans WK, et al. Tetracycline sclerosis in the management of malignant pericardial effusion. J Clin Oncol 1985; 3(12): 1678–82
   Google Scholar
• Press OW, Livingston R. Management of malignant pericardial effusion and tamponade. JAMA 1987; 257(8): 1088–92
   PubMed Web of Science ®Google Scholar
• Hankins JR, Satterfield JR, Aisner J, et al. Pericardial window for malignant pericardial effusion. Ann Thorac Surg 1980; 30(5): 465–71
   Google Scholar
• Hathorn JW, Lyke K. Empirical treatment of febrile neutropenia: evolution of current therapeutic approaches. Clin Infect Dis 1992; 24(Suppl 2): 256–65S
   Google Scholar
• Hughes WT, Armstrong D, Bodey GP, et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 1997; 25(3): 551–73
   Google Scholar
• Klastersky J. Treatment of neutropenic infection: trends towards monotherapy? Support Care Cancer 1997; 5(5): 365–70
   Google Scholar
• Karthaus M, Carratala J, Jurgens H, et al. New strategies in the treatment of infectious complications in haematology and oncology: is there a role for out-patient antibiotic treatment of febrile neutropenia? Chemotherapy 1998; 44(6): 427–35
   Google Scholar
• Karp JE, Dick JD, Angelopulos C, et al. Empiric use of vancomycin during prolonged treatment-induced granulocytopenia: a randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia. Am J Med 1986; 81(2): 237–42
   PubMed Web of Science ®Google Scholar
• Sugar AM. Empiric treatment of fungal infections in the neutropenic host: a review of the literature and guidelines for use. Arch Intern Med 1990; 150(11): 2258–64
   Google Scholar
• Pisciotto PT, Benson K, Hume H, et al. Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients. Transfusion 1995; 35(6): 498–502
   Google Scholar
• Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med 1997; 337(26): 1870–5
   PubMed Web of Science ®Google Scholar
• Engelfriet CP, Overbeeke MA, von dem Borne AE. Autoimmune hemolytic anemia. Semin Hematol 1992; 29(1): 3–12
   PubMed Web of Science ®Google Scholar
• Tabbara IA. Hemolytic anemias: diagnosis and management. Med Clin North Am 1992; 76(3): 649–68
   Google Scholar
• Di Raimondo F, Guistolisi R, Cacciola E, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine. Leuk Lymphoma 1993; 11(1–2): 63–8
   PubMed Web of Science ®Google Scholar
• Jefferies LC. Transfusion therapy in autoimmune hemolytic anemia. Hematol Oncol Clin North Am 1997; 8(6): 1087–104
   Google Scholar